2 résultats
Real-world efficacy of the dabrafenib-trametinib (D-T) combination in BRAF V600E-mutated metastatic non-small cell lung cancer (NSCLC): Results from the IFCT-2004 BLaDE cohort
Auteurs / Authors
Swalduz A, Beau-Faller M, Planchard D, Mazieres J, Bayle-Bleuez S, Debieuvre D, Fallet V, Geier M, Cortot A, Couraud S, Daniel C, Domblides C, Pichon E, Fabre E, Larivé S, Lerolle U, Tomasini P, Wislez M, Missy P, Morin F, Westeel V, Auliac JB.
Journal / Conference
Lung Cancer
Année / Year
2024
PMID / session
Etude IFCT
Efficacy of dabrafenib-trametinib combination in BRAF V600E-mutated metastatic non–small cell lung cancer: Results of the IFCT-2004 BLaDE cohort.
Auteurs / Authors
Swalduz A, Beau-Faller M, Planchard D, Mazieres J, Bayle S, Debieuvre D, Fallet V, Geier M, Cortot A, Couraud S, Daniel C, Pichon E, Missy P, Morin F, Westeel V, Auliac JB, Veillon R
Journal / Conference
ASCO
Année / Year
2022
PMID / session
Etude IFCT